News
Cuba''s Hemovigilance Results Similar to Wealthy Countries
Cuba has developed a hemovigilance program with results similar to those of industrialized nations, said a Cuban physician participating in the 7th Cuban Congress of Hematology (Hematology 2013).
Source
Prensa Latina
Date
Cuba has developed a hemovigilance program with results similar to those of industrialized nations, said a Cuban physician participating in the 7th Cuban Congress of Hematology (Hematology 2013).
The initiative, implemented for nine years in the western province of Matanzas as a national pilot program to be adopted throughout the country, was carried out without many resources, but with results comparable to those of wealthy countries, stated Doctor of Medical Science Hilda Maria Silva Ballester, of the "Minerva Duarte" Provincial Blood Bank in Matanzas.
Dr. Silva Ballester, who began developing a hemovigilance program in Cuba in 2003, told Prensa Latina the program began as a research project.
Only 20 countries in the world have implemented this kind of project, and some with a high level of development only introduced it a few years ago. The United States, for example, has only applied it since 2010, she said.
Although blood transfusion is generally quite safe worldwide, there are still risks that have increased the transmission of blood-borne infectious diseases, including those resulting from immune disorders, human errors, and faulty blood storage, among others, she said.
The initiative, implemented for nine years in the western province of Matanzas as a national pilot program to be adopted throughout the country, was carried out without many resources, but with results comparable to those of wealthy countries, stated Doctor of Medical Science Hilda Maria Silva Ballester, of the "Minerva Duarte" Provincial Blood Bank in Matanzas.
Dr. Silva Ballester, who began developing a hemovigilance program in Cuba in 2003, told Prensa Latina the program began as a research project.
Only 20 countries in the world have implemented this kind of project, and some with a high level of development only introduced it a few years ago. The United States, for example, has only applied it since 2010, she said.
Although blood transfusion is generally quite safe worldwide, there are still risks that have increased the transmission of blood-borne infectious diseases, including those resulting from immune disorders, human errors, and faulty blood storage, among others, she said.